$100,000 of LEGEND BIOTECH CORPORATION lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Advance Legend Biotech's ...
ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...
Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...
The need to harness and tap into numerous benefits of Genetically Modified Organisms (GMOS) has become paramount in the prevailing food insecurity being witness in the country. However, the battle for ...